z-logo
open-access-imgOpen Access
Changes in the Sensitivity of Erwinia amylovora Populations to Streptomycin and Oxolinic Acid in Israel
Author(s) -
Shulamit Manulis,
Frida Kleitman,
D. Shtienberg,
H. Shwartz,
D. Oppenheim,
Miriam Zilberstaine,
E. Shabi
Publication year - 2003
Publication title -
plant disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.663
H-Index - 108
eISSN - 1943-7692
pISSN - 0191-2917
DOI - 10.1094/pdis.2003.87.6.650
Subject(s) - fire blight , oxolinic acid , erwinia , streptomycin , biology , pear , orchard , antibacterial agent , pome , horticulture , microbiology and biotechnology , veterinary medicine , antibiotics , bacteria , antibiotic resistance , nalidixic acid , medicine , genetics
A survey of streptomycin resistance in the fire blight pathogen, Erwinia amylovora, conducted in pear, apple, and quince orchards in Israel during 1998 to 2001 revealed a decrease in the frequency of locations with streptomycin-resistant strains, from 57% in 1998 to 15% in 2001. In 2001, streptomycin-resistant strains were detected in only five locations in two restricted areas in western Galilee and the Golan Heights, compared with 16 locations found in 1998 throughout the northern part of the country. Since the use of streptomycin for fire blight control was terminated in 1997, this antibiotic has been replaced with oxolinic acid (Starner) in commercial orchards. Strains resistant to oxolinic acid were isolated from two pear orchards in the northern part of Israel in 1999. In a nationwide survey conducted during the spring and winter of 2000 and 2001, 51 and 47 pome fruit orchards, respectively, were sampled. Oxolinic acid-resistant strains were detected in several orchards located in two restricted areas in northern Galilee. Strains with resistance to both streptomycin and oxolinic acid were not found during 2000 to 2001. Results of this survey are used in managing fire blight with bactericides.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here